This inventor holds 1 USPTO granted patent. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hardwin O′dowd: Innovator in APOL1-Mediated Disease Treatment
Introduction: Hardwin O′dowd is a notable inventor based in Cambridge, MA (US), recognized for his contributions to the field of medical research. He holds a patent that focuses on inhibitors of APOL1, which are crucial in treating various diseases.
Latest Patents: Hardwin O′dowd's patent, titled "Inhibitors of APOL1 and methods of using same," provides innovative compounds and methods for treating APOL1-mediated diseases. This includes conditions such as pancreatic cancer, focal segmental glomerulosclerosis (FSGS), and non-diabetic kidney disease (NDKD).
Career Highlights: O′dowd is currently associated with Vertex Pharmaceuticals, Inc., where he applies his expertise in developing therapeutic solutions. His work has significantly impacted the understanding and treatment of kidney-related diseases.
Collaborations: Throughout his career, Hardwin has collaborated with esteemed colleagues, including Jun Myun Ahn and Samantha Angle. These partnerships have fostered advancements in research and development within the pharmaceutical industry.
Conclusion: Hardwin O′dowd's innovative work in the field of APOL1-mediated diseases exemplifies the importance of research and invention in improving healthcare outcomes. His contributions continue to pave the way for new treatment options and enhance the understanding of complex medical conditions
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile